Osteopontin is a marker for cancer aggressiveness and patient survival - Weber, G F; Lett, G S; Haubein, N C (British journal of cancer, 2010)
Keywords: 631/67/322; 692/53/2422; 692/699/67; 692/700/1750; Algorithms; Biological and medical sciences; Biomarkers; Biomarkers, Tumor - metabolism; Biomedical and Life Sciences; Biomedicine; Breast cancer; Cancer Research; Data analysis; Datasets; Drug Resistance; Epidemiology; Head & neck cancer; Human subjects; Humans; Interlibrary loans; Keywords; Liver cancer; Lung cancer; Medical research; Medical sciences; Melanoma; Metastasis; Molecular Diagnostics; Molecular Medicine; Neoplasms - metabolism; Neoplasms - pathology; Oncology; Osteopontin - metabolism; Prostate cancer; Skin cancer; Survival Analysis; Tumors; United States--US; stage; metastasis; survival; grade; Human; Biological marker; Osteopontin; Malignancy; Metastasis; Malignant tumor; Survival; Clinical stage; Cancerology; Aggressiveness; Cancer